Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05017948 · ClinicalTrials.gov registry record · NA

Alleviating Geriatric Inpatients' Medication-related Iatrogenesis

A NA study, sponsored by Rutgers, The State University of New Jersey.

Completed
Registry status
NA
Development phase
60
Enrollment target

NCT05017948 is a NA study that has completed, run by Rutgers, The State University of New Jersey. The registered enrollment target is 60 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05017948, a NA study, has completed, sponsored by Rutgers, The State University of New Jersey.

COMPLETED
Registry status
NA
Development phase
60 participants
Enrollment target

Study Summary

This study will evaluate the MedWise Risk Score™ (MWRS™), a holistic approach to quantifying the risk of a patient's medication regimen. High risk patients will be identified at hospital discharge. Targeted interventions will be made to reduce their MWRS™ with a 30-day follow up. The hypothesis being tested is that a reduction in MWRS™ will lead to reduced 30-day readmission.

Interventions

  • OTHER Risk score based intervention

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2021-09-15
Est. Completion 2023-11-01
Phase NA

What the Registry Record Tells You About NCT05017948

The ClinicalTrials.gov registry entry for NCT05017948 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Rutgers, The State University of New Jersey, which has 413 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Risk score based intervention is the first listed.

NCT05017948 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT05017948 about?

NCT05017948 is a clinical study titled "Alleviating Geriatric Inpatients' Medication-related Iatrogenesis". This study will evaluate the MedWise Risk Score™ (MWRS™), a holistic approach to quantifying the risk of a patient's medication regimen. High risk patients will be identified at hospital discharge. Targeted interventions will be made to reduce their MWRS™ with a 30-day follow up. The hypothesis bein...

What is the current status of trial NCT05017948?

This trial is currently completed. It is a NA study. The enrollment target is 60 participants. The study started on 2021-09-15. Estimated completion is 2023-11-01.

What interventions are being tested in trial NCT05017948?

The interventions under investigation include: Risk score based intervention (OTHER).

Who is sponsoring clinical trial NCT05017948?

This trial is sponsored by Rutgers, The State University of New Jersey, which has 413 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.